Article info

Download PDFPDF
The use of continuous infusion topotecan in persistent and recurrent ovarian cancer

Authors

  • J. C. Elkas Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California PubMed articlesGoogle scholar articles
  • C. H. Holschneider Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California PubMed articlesGoogle scholar articles
  • B. Katz Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California PubMed articlesGoogle scholar articles
  • A. J. Li Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California PubMed articlesGoogle scholar articles
  • R. Louie Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California PubMed articlesGoogle scholar articles
  • K. F. Mcgonigle Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California PubMed articlesGoogle scholar articles
  • J. S. Berek Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to: Jonathan Berek, MD, Division of Gynecologic Oncology Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Center for Health Sciences, 10833 Le Conte Avenue, Los Angeles, California 90095–1740, Email: jberek{at}mednet.ucla.edu.

Citation

Elkas JC, Holschneider CH, Katz B, et al
The use of continuous infusion topotecan in persistent and recurrent ovarian cancer

Publication history

  • First published February 1, 2003.
Online issue publication 
February 01, 2003

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.